Clicky

Health

Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil)
440 386 George

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing, and commercializing novel, patent protected products in selected specialty, rare and ultra-rare disease areas on a global basis, today announced promising six-month stability…

  • George
  • 0
  • 0

Bring the Family Together with Breakfast for Dinner
150 150 Rick

Despite busy lives and full schedules, finding time for regular meals with loved ones encourages connections and conversations that can benefit mental and physical well-being. Gathering your family, friends, coworkers or neighbors at least once…

  • Rick
  • 0
  • 0

Show Your Love with a Naturally Sweet, Delicious Gift
2278 1500 Jessi

 (Family Features) Whether you’re celebrating a special occasion, saying “I love you” to a faraway relative or offering a kind gesture to a friend or neighbor, sending a gift is a thoughtful way to share…

  • Jessi
  • 0
  • 0

Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day
1200 277 Lauren

Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefit Interim data from Phase 1/2 glycogen storage disease 1a…

  • Lauren
  • 0
  • 0

EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna’s Omicron-Targeting Bivalent Booster in the European Union
1200 277 Riley

CAMBRIDGE, MA / ACCESSWIRE / September 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…

  • Riley
  • 0
  • 0

Moderna to Host R&D Day on Thursday, September 8, 2022
1200 277 Lauren

CAMBRIDGE, MA / ACCESSWIRE / August 29, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it will host its in-person and virtual R&D Day at 9:00 a.m.…

  • Lauren
  • 0
  • 0

Empower Clinics Maintains Strong Volume for Its COVID-19 Testing Solutions in Vancouver
270 50 Rick

VANCOUVER, BC / ACCESSWIRE / August 5, 2022 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms, a medical device company, and a high…

  • Rick
  • 0
  • 0

Health Canada Authorizes Moderna’s COVID-19 Vaccine in Young Children (6 Months-5 Years)
1200 277 Rick

CAMBRIDGE, MA / ACCESSWIRE / July 14, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Health Canada has approved the use of Moderna’s mRNA COVID-19 vaccine,…

  • Rick
  • 0
  • 0

International Meeting of Catholic Scholars and Lawyers on COVID-19 Measures Wraps up in Rome: Aquinas, Law & Politics in Times of COVID: 24-25 June 2022
150 150 Jessi

ROME, ITALY / ACCESSWIRE / June 29, 2022 / After two years of COVID-19 policies, an International group of Catholic scholars and lawyers gathered under the auspices of the International Catholic Jurists Forum (ICJF) to study the theme…

  • Jessi
  • 0
  • 0